• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday

    10/7/22 6:29:20 AM ET
    $AGEN
    $ANGO
    $APLT
    $AREB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $AGEN alert in real time by email

    Gainers

    • Green Giant Inc. (NASDAQ:GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.
    • Atlis Motor Vehicles, Inc. (NASDAQ:AMV) climbed 95.5% to close at $24.49.
    • InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) gained 83% to settle at $7.98.
    • Pineapple Energy Inc. (NASDAQ:PEGY) shares climbed 64.9% to close at $4.55 after jumping 93% on Wednesday. Pineapple Energy recently named Eric Ingvaldson as new Chief Financial Officer.
    • WM Technology, Inc. (NASDAQ:MAPS) rose 64.3% to close at $2.76.
    • Statera Biopharma, Inc. (NASDAQ:STAB) gained 62.8% to close at $0.2283 on Thursday. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of Radiation-Related Disorders."
    • Code Chain New Continent Limited (NASDAQ:CCNC) shares gained 46.6% to close at $0.2465.
    • SpringBig Holdings, Inc. (NASDAQ:SBIG) jumped 44.2% to close at $1.19.
    • Kiromic BioPharma, Inc. (NASDAQ:KRBP) gained 44.3% to close at $0.3923 after the company announced it received feedback from the FDA pursuant to its Type B Pre-IND meeting request regarding its Deltacel development strategy.
    • Clever Leaves Holdings Inc. (NASDAQ:CLVR) jumped 36.7% to settle at $0.8198.
    • Motus GI Holdings, Inc. (NASDAQ:MOTS) rose 38.3% to close at $2.60 after the company was granted a Us patent titled 'Cleaning Method for Prepless Colonoscopy.'
    • Guardion Health Sciences, Inc. (NASDAQ:GHSI) jumped 31% to close at $0.1808 as the company announced clinical results indicating viactiv omega boost gel bites showed increase in Omega-3 levels in 4 weeks.
    • Tilray Brands, Inc. (NASDAQ:TLRY) gained 30.9% to settle at $3.90. Shares of cannabis companies traded higher after President Biden issued a statement on marijuana reform, which mentioned pardoning 'all prior federal offenses of simple marijuana possession.'
    • SAI.TECH Global Corporation (NASDAQ:SAI) rose 30.4% to settle at $4.89.
    • BioSig Technologies, Inc. (NASDAQ:BSGM) jumped 28.8% to settle at $0.88.
    • Addentax Group Corp. (NASDAQ:ATXG) gained 28.4% to close at $3.44.
    • COMSovereign Holding Corp. (NASDAQ:COMS) rose 26.9% to settle at $0.0773.
    • HeartBeam, Inc. (NASDAQ:BEAT) shares climbed 26.5% to close at $5.73 after the company announced it expanded its product portfolio pipeline to include smartwatch connectivity.
    • DAVIDsTEA Inc. (NASDAQ:DTEA) climbed 26% to close at $0.8948.
    • WeTrade Group, Inc. (NASDAQ:WETG) rose 25.8% to close at $1.16.
    • Provention Bio, Inc. (NASDAQ:PRVB) surged 25.7% to close at $6.22 after the company announced it has entered into a co-promotion agreement with Sanofi U.S. for the launch of its lead investigational drug candidate teplizumab.
    • The Valens Company Inc. (NASDAQ:VLNS) rose 25.1% to settle at $0.8871.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) gained 25% to close at $2.90. The company recently announced new distributor agreements in Germany.
    • Richardson Electronics, Ltd. (NASDAQ:RELL) gained 24.6% to close at $19.12 following upbeat Q1 results.
    • BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) rose 23.6% to close at $2.72.
    • Senti Biosciences, Inc. (NASDAQ:SNTI) gained 23.5% to close at $6.52.
    • SNDL Inc. (NASDAQ:SNDL) rose 23.5% to close at $2.79. Shares of cannabis companies traded higher after President Biden issued a statement on marijuana reform, which mentioned pardoning 'all prior federal offenses of simple marijuana possession.'
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) climbed 23.5% to close at $0.1274.
    • Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) rose 23.4% to settle at $0.2098.
    • Canopy Growth Corporation (NASDAQ:CGC) jumped 22.2% to close at $3.75. Shares of cannabis companies traded higher after President Biden issued a statement on marijuana reform, which mentioned pardoning 'all prior federal offenses of simple marijuana possession.'
    • Rain Therapeutics Inc. (NASDAQ:RAIN) gained 19.5% to close at $4.71.
    • Agenus Inc. (NASDAQ:AGEN) climbed 18.1% to close at $2.80.
    • Compass, Inc. (NYSE:COMP) jumped 16.1% to close at $2.96.
    • Innovid Corp. (NYSE:CTV) gained 15.7% to close at $2.72.
    • PureTech Health plc (NASDAQ:PRTC) rose 14.9% to close at $31.01.
    • Plus Therapeutics, Inc. (NASDAQ:PSTV) gained 14.7% to close at $0.5450. Plus Therapeutics recently reported it finalized and signed a grant contract with the Cancer Prevention & Research Institute of Texas for its previously announced $17.6 million Product Development Research funding award.
    • Revelation Biosciences, Inc. (NASDAQ:REVB) gained 14.4% to close at $0.2901 after the company announced an exclusive worldwide license agreement with Vanderbilt University to develop and commercialize phosphorylated hexaacyl disaccharide, for treating or preventing infections.
    • Zovio Inc (NASDAQ:ZVO) rose 14% to close at $0.1670 after declining around 7% on Wednesday.
    • DiaMedica Therapeutics Inc. (NASDAQ:DMAC) rose 13.7% to close at $1.33.
    • Cronos Group Inc. (NASDAQ:CRON) jumped 13.5% to close at $3.36. Shares of cannabis companies traded higher after President Biden issued a statement on marijuana reform, which mentioned pardoning 'all prior federal offenses of simple marijuana possession.'
    • BZ Wire
    • Perion Network Ltd. (NASDAQ:PERI) gained 13% to close at $23.01. Perion issued preliminary Q3 results. The company said it sees Q3 revenue of $158 million.
    • Avadel Pharmaceuticals plc (NASDAQ:AVDL) rose 12.7% to close at $6.46.
    • Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) gained 11.5% to close at $2.90. Lixiang Education Holding recently posted 1H loss of $0.01 per share.
    • TOP Financial Group Limited (NASDAQ:TOP) rose 10.2% to close at $17.90.
    • WISeKey International Holding AG (NASDAQ:WKEY) rose 6.6% to close at $1.79 after the company reported 9-Month preliminary results, The company reported revenue of $20.5 million, a 69% increase from the year-ago period.
    • Pinterest, Inc. (NYSE:PINS) rose 4.9% to close at $25.83. Goldman Sachs upgraded Pinterest from Neutral to Buy and raised the price target from $24 to $31.


    Don’t forget to check out our premarket coverage here .


    Losers

    • Jowell Global Ltd. (NASDAQ:JWEL) shares fell 45.4% to close at $1.53. Jowell Global recently posted 1H loss of $0.30 per share.
    • Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) fell 37.6% to close at $ 0.5870 after the company announced a mitochondrial disease-focused strategy. The plan will include a 45% workforce reduction.
    • Top Ships Inc. (NASDAQ:TOPS) fell 35.2% to close at $6.40 after jumping 82% on Wednesday. TOP Ships recently announced 1H FY22 revenue of $38.8 million.
    • Applied Therapeutics, Inc. (NASDAQ:APLT) dropped 33.5% to close at $0.6320 after the company disclosed data trend in AT-007 ACTION-galactosemia kids pediatric trial. The company said 'The study did not yet reach statistical significance at 12 months of treatment.'
    • Chardan NexTech Acquisition 2 Corp. (NASDAQ:CNTQ) fell 30.4% to close at $15.24 after jumping around 103% on Wednesday.
    • Nutex Health Inc. (NASDAQ:NUTX) fell 26.3% to close at $0.8998.
    • American Rebel Holdings, Inc. (NASDAQ:AREB) shares fell 26% to close at $0.37 after jumping 16% on Wednesday.
    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) fell 25.8% to close at $0.2462 after jumping 72% on Wednesday.
    • Avenue Therapeutics, Inc. (NASDAQ:ATXI) fell 25.7% to close at $6.29. Avenue Therapeutics priced its 3.6 million unit offering at $3.30 per unit.
    • AngioDynamics, Inc. (NASDAQ:ANGO) dropped 19.5% to close at $17.34 after the company reported worse-than-expected Q1 results.
    • Super League Gaming, Inc. (NASDAQ:SLGG) dropped 19.2% to close at $0.7512.
    • FingerMotion, Inc. (NASDAQ:FNGR) fell 19% to close at $7.18 after jumping 29% on Wednesday.
    • FOXO Technologies Inc. (NYSE:FOXO) fell 18% to close at $1.32.
    • Gold Royalty Corp. (NYSE:GROY) dropped 16.6% to close at $2.37.
    • Integer Holdings Corporation (NYSE:ITGR) fell 16.6% to close at $55.28. Integer sees preliminary Q3 revenue of $342 million to $344 million and adjusted EPS of $0.86-$0.99.
    • United Time Technology Co., Ltd. (NASDAQ:UTME) dropped 16% to $1.68.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) fell 14.3% to close at $0.1384. HC Wainwright & Co. downgraded Esports Entertainment from Buy to Neutral and lowered the price target from $1.5 to $0.15.
    • Li Auto Inc. (NASDAQ:LI) dropped 12.3% to close at $20.95.
    • Spark Networks SE (NASDAQ:LOV) dipped 11.4% to close at $2.17.
    • 5E Advanced Materials Inc. (NASDAQ:FEAM) fell 11.4% to close at $11.70. Baird maintained an Outperform rating on the stock and lowered its price target from $36 to $21.
    • Resources Connection, Inc. (NASDAQ:RGP) fell 9.9% to close at $16.18 following Q1 results.
    • Altice USA, Inc. (NYSE:ATUS) dropped 8.9% to close at $5.75.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) dropped 8.8% to close at $1.56.
    • Waste Connections, Inc. (NYSE:WCN) dropped 65% to close at $134.72.
    Get the next $AGEN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGEN
    $ANGO
    $APLT
    $AREB

    CompanyDatePrice TargetRatingAnalyst
    Integer Holdings Corporation
    $ITGR
    2/20/2026$95.00Hold → Buy
    The Benchmark Company
    Pinterest Inc.
    $PINS
    2/13/2026$16.00Buy → Hold
    Deutsche Bank
    Pinterest Inc.
    $PINS
    2/13/2026$17.00Outperform → Sector Perform
    RBC Capital Mkts
    Pinterest Inc.
    $PINS
    2/13/2026$20.00Overweight → Neutral
    Analyst
    Pinterest Inc.
    $PINS
    2/13/2026$20.00Outperform → Neutral
    Robert W. Baird
    Pinterest Inc.
    $PINS
    2/13/2026$19.00Buy → Neutral
    Citigroup
    Pinterest Inc.
    $PINS
    2/13/2026$19.00Buy → Neutral
    BofA Securities
    Pinterest Inc.
    $PINS
    2/13/2026$25.00Outperform → In-line
    Evercore ISI
    More analyst ratings

    $AGEN
    $ANGO
    $APLT
    $AREB
    SEC Filings

    View All

    Compass Inc. filed SEC Form 8-K: Leadership Update

    8-K - Compass, Inc. (0001563190) (Filer)

    2/23/26 4:13:23 PM ET
    $COMP
    EDP Services
    Technology

    Avenue Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - AVENUE THERAPEUTICS, INC. (0001644963) (Filer)

    2/23/26 4:06:15 PM ET
    $ATXI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by WISeKey International Holding Ltd

    6-K - Wisekey International Holding S.A. (0001738699) (Filer)

    2/23/26 9:22:49 AM ET
    $WKEY
    EDP Services
    Technology

    $AGEN
    $ANGO
    $APLT
    $AREB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bep Special Situations Iv Llc bought $8,000,000 worth of shares (4,000,000 units at $2.00) (SEC Form 4)

    4 - 5E Advanced Materials, Inc. (0001888654) (Issuer)

    2/4/26 4:30:07 PM ET
    $FEAM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    CFO Malm Joshua bought $7,500 worth of shares (3,750 units at $2.00), increasing direct ownership by 263% to 5,175 units (SEC Form 4)

    4 - 5E Advanced Materials, Inc. (0001888654) (Issuer)

    2/3/26 4:03:48 PM ET
    $FEAM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    Chief Executive Officer Weibel Paul Wesley Iii bought $7,500 worth of shares (3,750 units at $2.00), increasing direct ownership by 25% to 18,838 units (SEC Form 4)

    4 - 5E Advanced Materials, Inc. (0001888654) (Issuer)

    2/3/26 4:03:16 PM ET
    $FEAM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    $AGEN
    $ANGO
    $APLT
    $AREB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AngioDynamics to Present at the Leerink Partners Global Healthcare Conference

    AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced, that Jim Clemmer, President and Chief Executive Officer, will present at the Leerink Partners Global Healthcare Conference on Monday, Mar. 9, 2026. The Company's presentation will begin at 1:40 p.m. (ET). A live webcast of the event will be accessible through the "Investors" section of the Company's website at www.angiodynamics.com and will be available for replay following the event. About AngioDynamics, Inc. AngioDynamics is a leading

    2/23/26 4:30:00 PM ET
    $ANGO
    Medical/Dental Instruments
    Health Care

    Century 21 Real Estate Announces its 2025 GLOBAL 21, Honoring Leading Real Estate Achievers Across its International Network

    MADISON, N.J., Feb. 23, 2026 /PRNewswire/ -- Century 21 Real Estate LLC, a subsidiary of Compass International Holdings (NYSE:COMP), today announced the CENTURY 21® brand's 2025 GLOBAL 21® honorees, recognizing the top 21 companies, offices, producers, and teams from across its worldwide network based on Adjusted Gross Commission (AGC)*. Representing markets across North America, Asia, and Europe, this prestigious list showcases the affiliated real estate professionals who delivered exceptional results and elevated the standard of excellence across the global CENTURY 21 system.

    2/23/26 12:15:00 PM ET
    $COMP
    EDP Services
    Technology

    Century 21 Real Estate Reveals its 2025 "Number Ones," Honoring the Brand's Highest Performers Worldwide

    MADISON, N.J., Feb. 23, 2026 /PRNewswire/ -- Century 21 Real Estate LLC, a subsidiary of Compass International Holdings (NYSE:COMP), today announced the real estate entrepreneurs, offices, teams, and producers who earned the distinction of being the CENTURY 21® network's 2025 "Number Ones*". The annual recognition is awarded to professionals affiliated with the brand who set the pace for excellence, delivering standout performance and industry leading service in markets across the globe. The CENTURY 21 award-winning franchised companies, offices, producers, and teams for 2025 ar

    2/23/26 11:15:00 AM ET
    $COMP
    $HOUS
    EDP Services
    Technology
    Real Estate
    Finance

    $AGEN
    $ANGO
    $APLT
    $AREB
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for TZIELD issued to PROVENTION BIO INC

    Submission status for PROVENTION BIO INC's drug TZIELD (ORIG-1) with active ingredient TEPLIZUMAB-MZWV has changed to 'Approval' on 11/17/2022. Application Category: BLA, Application Number: 761183, Application Classification:

    11/21/22 12:03:06 AM ET
    $PRVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGEN
    $ANGO
    $APLT
    $AREB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Acosta Andrea covered exercise/tax liability with 7,968 shares, decreasing direct ownership by 6% to 132,842 units (SEC Form 4)

    4 - PINTEREST, INC. (0001506293) (Issuer)

    2/23/26 5:20:01 PM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    Chief Technology Officer Madrigal Matthew covered exercise/tax liability with 19,529 shares, decreasing direct ownership by 2% to 993,219 units (SEC Form 4)

    4 - PINTEREST, INC. (0001506293) (Issuer)

    2/23/26 5:19:35 PM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    CFO, CAO, Corporate Secretary Ben Robert J sold $51,948 worth of shares (4,000 units at $12.99), decreasing direct ownership by 7% to 53,034 units (SEC Form 4)

    4 - RICHARDSON ELECTRONICS, LTD. (0000355948) (Issuer)

    2/23/26 2:45:28 PM ET
    $RELL
    Electronic Components
    Technology

    $AGEN
    $ANGO
    $APLT
    $AREB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Integer Holdings upgraded by The Benchmark Company with a new price target

    The Benchmark Company upgraded Integer Holdings from Hold to Buy and set a new price target of $95.00

    2/20/26 8:20:06 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Pinterest downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded Pinterest from Buy to Hold and set a new price target of $16.00

    2/13/26 10:37:47 AM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    Pinterest downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Pinterest from Outperform to Sector Perform and set a new price target of $17.00

    2/13/26 9:34:47 AM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    $AGEN
    $ANGO
    $APLT
    $AREB
    Leadership Updates

    Live Leadership Updates

    View All

    Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board

    –Received Positive Pre-Investigational New Drug ("IND") Written Feedback from the U.S. Food and Drug Administration ("FDA")– –Clinical Advisory Board ("CAB") Includes Key Leaders across Neuropsychiatry, Anesthesiology, and Clinical Development– –Remain On Track to Initiate CYC-126's Phase 2 Proof-of-Concept ("POC") Study in Treatment Resistant Depression ("TRD") in the Second Half of 2026– CAMBRIDGE, Mass., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) ("Cyclerion" or "Company"), a biopharmaceutical company pioneering neuropsychiatric therapies, today announced it has received positive written regulatory feedback and responses from the FDA on CYC-126

    2/17/26 7:00:00 AM ET
    $CYCN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary

    WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary Geneva, Switzerland, February 10, 2026 – WISeKey International Holding Ltd ("WISeKey" or the "Company") ((SIX: WIHN, NASDAQ:WKEY), a global leader in cybersecurity, digital identity and Internet of Things (IoT) solutions, today announced the appointment of Gwenael Rouy-Poirier as Chief Financial Officer of its subsidiary WISeSat.Space Corp. ("WISeSat") specialized in space-technology and secure satellite communications for IoT applications, effective February 2, 2026. Of note, in November 2025, WISeSat announced a Business Combination Agreement with Columbus Acquisition Corp.

    2/10/26 1:00:00 AM ET
    $CODA
    $COLA
    $LAES
    Industrial Machinery/Components
    Industrials
    Semiconductors
    Technology

    Pinterest Appoints Kecia Steelman to Board of Directors

    Pinterest, Inc. (NYSE:PINS) today announced that Kecia Steelman, President and Chief Executive Officer of Ulta Beauty, has been appointed to the company's Board of Directors, effective February 16, 2026. "Kecia is a seasoned executive with deep experience leading large-scale businesses and connecting consumers with brands they love," said Bill Ready, Chief Executive Officer of Pinterest. "Her track record of growing global businesses, building omnichannel experiences, and partnering closely with brands will be an asset as we continue to transform Pinterest into the leading visual discovery and AI-powered shopping platform, especially for Gen Z." Steelman joined Ulta Beauty in 2014 and h

    2/9/26 4:50:00 PM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    $AGEN
    $ANGO
    $APLT
    $AREB
    Financials

    Live finance-specific insights

    View All

    Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development

    SOUTH SAN FRANCISCO, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (NASDAQ:SNTI) ("Senti Bio"), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that it participated in a Cell & Gene Live virtual event focused on emerging and enabling technologies designed to advance the development of innovative cell therapies. The Cell & Gene Live webinar, held on February 19, 2026, convened industry leaders and innovators to discuss approaches aimed at improving the design, development and translation of cell therapies. The Company shared perspectives on how its Gene Circuit-based a

    2/20/26 8:50:00 AM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SNDL to Report Fourth Quarter 2025 and Full Year 2025 Financial Results on March 12, 2026

    EDMONTON, Alberta, Feb. 19, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ:SNDL, CSE:SNDL) ("SNDL") announced today that it will release its fourth quarter and full year 2025 financial results for the period ended December 31, 2025, before markets open on Thursday, March 12, 2026. Following the release of its fourth quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on March 12, 2026. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/aps8jm4e ABOUT SNDL INC.  SNDL Inc. (NASDAQ:SNDL, CSE:SNDL), through its wholly owned subsidiaries, is one of the largest vertically integr

    2/19/26 4:30:00 PM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

    Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2025

    ~ Delivered 8% sales growth and 21% adjusted EPS growth in full year 2025 ~ ~ 2026 Outlook maintains midpoint of sales growth and high end of adjusted EPS growth from October outlook ~~ Continue to expect 200bps above-market organic sales growth in 2027 ~ PLANO, Texas, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading contract development and manufacturing organization, today announced results for the three and twelve months ended December 31, 2025. Unless otherwise stated, all results and comparisons are from continuing operations. Fourth Quarter 2025 Financial Results (compared to fourth quarter 2024, except as noted) Sales increased 5% to $472 mill

    2/19/26 8:00:00 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AGEN
    $ANGO
    $APLT
    $AREB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Pinterest Inc.

    SC 13G/A - PINTEREST, INC. (0001506293) (Subject)

    12/6/24 10:11:26 AM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13D/A filed by Senti Biosciences Inc.

    SC 13D/A - Senti Biosciences, Inc. (0001854270) (Subject)

    12/4/24 7:08:03 PM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Gold Royalty Corp.

    SC 13G/A - Gold Royalty Corp. (0001834026) (Subject)

    11/15/24 4:37:48 PM ET
    $GROY
    Precious Metals
    Basic Materials